Abstract
Background: This chapter reports the evaluation of two shotgun metaproteomic workflows. The methods were developed to investigate gut dysbiosis via analysis of the faecal microbiota from patients with cystic fibrosis (CF). We aimed to set up an unbiased and effective method to extract the entire proteome, i.e. to extract sufficient bacterial proteins from the faecal samples in combination with a maximum of host proteins giving information on the disease state.
Methods: Two protocols were compared; the first method involves an enrichment of the bacterial proteins while the second method is a more direct method to generate a whole faecal proteome extract. The different extracts were analysed using denaturing polyacrylamide gel electrophoresis followed by liquid chromatography-tandem mass spectrometry aiming a maximal coverage of the bacterial protein content in faecal samples.
Results and conclusions: In all extracts, microbial proteins are detected, and in addition, nonbacterial proteins are detected in all samples providing information about the host status. Our study demonstrates the huge influence of the used protein extraction method on the obtained result and shows the need for a standardised and appropriate sample preparation for metaproteomic analysis. To address questions on the health status of the patients, a whole protein extract is preferred over a method to enrich the bacterial fraction. In addition, the method of the whole protein fraction is faster, which gives the possibility to analyse more biological replicates.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
Since 2013, the database has been dramatically increased, e.g. by inclusion of several metagenomics projects. Therefore, the number of identified peptides/proteins could probably be improved by researching data against recent updates of the database. However, the aim of this paper is to compare protocols, and the main conclusions do not depend on the database used.
References
Dethlefsen L, Eckburg PB, Bik EM et al (2006) Assembly of the human intestinal microbiota. Trends Ecol Evol 21:517–523
Gill SR, Pop M, DeBoy RT et al (2006) Metagenomic analysis of the human distal gut microbiome. Science 312:1355–1359
Cummings JH, Macfarlane GT (1997) Role of intestinal bacteria in nutrient metabolism. JPEN J Parenter Enteral Nutr 21:357–365
Guarner F, Malagelada JR (2003) Gut flora in health and disease. Lancet 361:512–519
Sekirov I, Russell SL, Antunes LC et al (2010) Gut microbiota in health and disease. Physiol Rev 90:859–904
Pryde SE, Duncan SH, Hold GL et al (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217:133–139
Ubeda C, Pamer EG (2012) Antibiotics, microbiota, and immune defense. Trends Immunol 33:459
Mortensen PB, Clausen MR (1996) Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand J Gastroenterol Suppl 216:132–148
Barcenilla A, Pryde SE, Martin JC et al (2000) Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66:1654–1661
Duytschaever G, Huys G, Bekaert M et al (2013) Dysbiosis of bifidobacteria and Clostridium cluster XIVa in the cystic fibrosis fecal microbiota. J Cyst Fibros 12:206–215
Tannock GW (2008) The search for disease-associated compositional shifts in bowel bacterial communities of humans. Trends Microbiol 16:488–495
Larsen N, Vogensen FK, van den Berg FW et al (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5:e9085
van Tongeren SP, Slaets JP, Harmsen HJ et al (2005) Fecal microbiota composition and frailty. Appl Environ Microbiol 71:6438–6442
Balamurugan R, Rajendiran E, George S et al (2008) Real-time polymerase chain reaction quantification of specific butyrate-producing bacteria, Desulfovibrio and Enterococcus faecalis in the feces of patients with colorectal cancer. J Gastroenterol Hepatol 23:1298–1303
Davies JC, Bilton D (2009) Bugs, biofilms, and resistance in cystic fibrosis. Respir Care 54:628–640
Wilschanski M, Durie PR (2007) Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 56:1153–1163
O’Brien S, Mulcahy H, Fenlon H et al (1993) Intestinal bile acid malabsorption in cystic fibrosis. Gut 34:1137–1141
Duytschaever G, Huys G, Bekaert M et al (2011) Cross-sectional and longitudinal comparisons of the predominant fecal microbiota compositions of a group of pediatric patients with cystic fibrosis and their healthy siblings. Appl Environ Microbiol 77:8015–8024
Bruzzese E, Raia V, Gaudiello G et al (2004) Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 20:813–819
Hawrelak JA, Myers SP (2004) The causes of intestinal dysbiosis: a review. Altern Med Rev 9:180–197
Modolell I, Guarner L, Malagelada JR (2002) Digestive system involvement in cystic fibrosis. Pancreatology 2:12–16
Verberkmoes NC, Russell AL, Shah M et al (2009) Shotgun metaproteomics of the human distal gut microbiota. ISME J 3:179–189
Rooijers K, Kolmeder C, Juste C et al (2011) An iterative workflow for mining the human intestinal metaproteome. BMC Genomics 12:6
Kolmeder CA, de Been M, Nikkila J et al (2012) Comparative metaproteomics and diversity analysis of human intestinal microbiota testifies for its temporal stability and expression of core functions. PLoS One 7:e29913
Keller A, Nesvizhskii AI, Kolker E et al (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 74:5383–5392
Nesvizhskii AI, Keller A, Kolker E et al (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 75:4646–4658
Mesuere B, Devreese B, Debyser G et al (2012) Unipept: tryptic peptide-based biodiversity analysis of metaproteome samples. J Proteome Res 11:5773–5780
Conesa A, Gotz S, Garcia-Gomez JM et al (2005) Blast2GO: a universal tool for annotation, visualization and analysis in functional genomics research. Bioinformatics 21:3674–3676
Quevillon E, Silventoinen V, Pillai S et al (2005) InterProScan: protein domains identifier. Nucleic Acids Res 33:W116–W120
Myhre S, Tveit H, Mollestad T et al (2006) Additional gene ontology structure for improved biological reasoning. Bioinformatics 22:2020–2027
Kanehisa M, Goto S, Sato Y et al (2012) KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 40:D109–D114
Detlefsen L, McFall-Ngai M, Relman DA (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449:811–818
Liu C, Finegold SM, Song Y et al (2008) Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 58:1896–1902
Gerritsen J, Smidt H, Rijkers GT et al (2011) Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6:209–240
Ben-Amor K, Heilig H, Smidt H et al (2005) Genetic diversity of viable, injured, and dead fecal bacteria assessed by fluorescence-activated cell sorting and 16S rRNA gene analysis. Appl Environ Microbiol 71:4679–4689
Bahl MI, Bergstrom A, Licht TR (2012) Freezing fecal samples prior to DNA extraction affects the Firmicutes to Bacteroidetes ratio determined by downstream quantitative PCR analysis. FEMS Microbiol Lett 329:193–197
Neilson KA, Ali NA, Muralidharan S et al (2011) Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 11:535–553
Okazaki N, Takahashi N, Kojima S et al (2002) Protocadherin LKC, a new candidate for a tumor suppressor of colon and liver cancers, its association with contact inhibition of cell proliferation. Carcinogenesis 23:1139–1148
Apajalahti JH, Sarkilahti LK, Maki BR et al (1998) Effective recovery of bacterial DNA and percent-guanine-plus-cytosine-based analysis of community structure in the gastrointestinal tract of broiler chickens. Appl Environ Microbiol 64:4084–4088
Kolmeder CA, de Vos WM (2014) Metaproteomics of our microbiome - developing insight in function and activity in man and model systems. J Proteome 97:3–16
Ham BM, Yang F, Jayachandran H et al (2008) The influence of sample preparation and replicate analyses on HeLa cell phosphoproteome coverage. J Proteome Res 7:2215–2221
Zhang X, Chen W, Ning Z et al (2017) Deep Metaproteomics approach for the study of human microbiomes. Anal Chem 89:9407–9415
Lozupone CA, Stombaugh JI, Gordon JI et al (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489:220–230
Duytschaever G, Huys G, Boulanger L et al (2013) Amoxicillin-clavulanic acid resistance in fecal Enterobacteriaceae from patients with cystic fibrosis and healthy siblings. J Cyst Fibros 12:780
Schippa S, Iebba V, Santangelo F et al (2013) Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients. PLoS One 8:e61176
Del Campo R, Garriga M, Perez-Aragon A et al (2014) Improvement of digestive health and reduction in proteobacterial populations in the gut microbiota of cystic fibrosis patients using a Lactobacillus reuteri probiotic preparation: a double blind prospective study. J Cyst Fibros 13:716–722
Sokol H, Seksik P, Furet JP et al (2009) Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15:1183–1189
Willing BP, Dicksved J, Halfvarson J et al (2010) A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139:1844–1854 e1841
Debyser G, Mesuere B, Clement L et al (2016) Faecal proteomics: a tool to investigate dysbiosis and inflammation in patients with cystic fibrosis. J Cyst Fibros 15:242–250
Ladirat SE, Schols HA, Nauta A et al (2013) High-throughput analysis of the impact of antibiotics on the human intestinal microbiota composition. J Microbiol Methods 92:387–397
Jernberg C, Lofmark S, Edlund C et al (2007) Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. ISME J 1:56–66
Jakobsson HE, Jernberg C, Andersson AF et al (2010) Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One 5:e9836
Perez-Cobas AE, Gosalbes MJ, Friedrichs A et al (2013) Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut 62:1591–1601
Turroni F, Peano C, Pass DA et al (2012) Diversity of Bifidobacteria within the infant gut microbiota. PLoS One 7:e36957
Acknowledgements
This research was supported by grant G.0638.10 from Research Foundation Flanders (FWO). PD acknowledges the support of Ghent University (MRP Bioinformatics: from nucleotides to networks). The authors thank Dr. Kris Moreel for the generous help with the LC-MS/MS analyses on the FT-ICR-MS.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Supplementary Data
Supplementary Data
Supplementary files can be downloaded from http://users.ugent.be/~bdevrees/.
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Debyser, G. et al. (2019). A Method for Comprehensive Proteomic Analysis of Human Faecal Samples to Investigate Gut Dysbiosis in Patients with Cystic Fibrosis. In: Capelo-Martínez, JL. (eds) Emerging Sample Treatments in Proteomics. Advances in Experimental Medicine and Biology(), vol 1073. Springer, Cham. https://doi.org/10.1007/978-3-030-12298-0_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-12298-0_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-12297-3
Online ISBN: 978-3-030-12298-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)